AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
Manuscript Number:
15-0834R1
Author(s):
Robert C. Alexander, Anna Bogstedt, Gvido Cebers, Susanna Eketjäll, Johanna Fälting, Samantha Budd Haeberlein, Juliette Janson, Fredrik Jeppsson, Karin Kaspersson, Alan R. Kugler
Disclosures
Robert C. Alexander
Sponsors:
Not currently but I was employed by AstraZeneca when the work was done.
Anna Bogstedt
Sponsors:
AstraZeneca employee
Gvido Cebers
Equity:
I own AstraZeneca stock in a mutual fund.
Sponsors:
I am employed by AstraZeneca Pharmaceuticals, have been since 2004.